Ticker: XBIO

Xenetic Biosciences, Inc. (NASDAQ: XBIO) Quick summary - what's happening inside * The company remains pre‑clinical, advancing its DNase oncology program and funding operations largely from legacy royalties and cash on hand. * Management says existing resources should fund operations for at least...